Advised a global real estate investment manager on its RMB2 billion acquisition of a portfolio of core logistic real estate assets in China.
Advised a Hong Kong listed company in its series B investment in a pharmaceutical company based in the United States.
Advising a large ink-maker in its proposed acquisition of chemicals manufacturers in the PRC.
Represented a global insurance company in its corporate and loan restructuring.
Represented a US based public relations firm in its substantial acquisition of an employment agency with operations in China and Singapore.
Represented a UK based construction company in the substantial disposal of its construction business in Hong Kong.
Represented a Hong Kong listed company on its acquisition of a US dental implant company with PRC distribution arrangements.
Assisted a NASDAQ listed medical devices corporation in its regulatory, compliance and distribution matters.
Representing an international travel corporation on its operational compliance issues.